High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: The BARI 2D baseline data

Barry Wall, Regina M. Hardison, Mark E. Molitch, Oscar C. Marroquin, Janet B. McGill, Phyllis A. August

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: We describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality. Methods: Study participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated. Results: Two thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23% had an eGFR ≥60 mL/min/1.73 m2 with either microalbuminuria (>30 ACR; 17%) or macroalbuminuria (>300 ACR; 6%). Twenty-one percent had a reduced eGFR <60 mL/min/1.73 m2; 52% with reduced eGFR had no albuminuria; 28% had microalbuminuria, and 20% had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR. Conclusion: Kidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33%. Reduced eGFR was present in 21%, and half the patients with reduced eGFR had no evidence of albuminuria.

Original languageEnglish (US)
Pages (from-to)401-410
Number of pages10
JournalAmerican Journal of the Medical Sciences
Volume339
Issue number5
DOIs
StatePublished - May 1 2010

Fingerprint

Albuminuria
Type 2 Diabetes Mellitus
Coronary Artery Disease
Kidney
Hemoglobins
Insulin
HDL Lipoproteins
Vascular Diseases
Angioplasty
Albumins
Creatinine
Triglycerides
Randomized Controlled Trials
Smoking
Hypertension
Mortality
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease : The BARI 2D baseline data. / Wall, Barry; Hardison, Regina M.; Molitch, Mark E.; Marroquin, Oscar C.; McGill, Janet B.; August, Phyllis A.

In: American Journal of the Medical Sciences, Vol. 339, No. 5, 01.05.2010, p. 401-410.

Research output: Contribution to journalArticle

Wall, Barry ; Hardison, Regina M. ; Molitch, Mark E. ; Marroquin, Oscar C. ; McGill, Janet B. ; August, Phyllis A. / High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease : The BARI 2D baseline data. In: American Journal of the Medical Sciences. 2010 ; Vol. 339, No. 5. pp. 401-410.
@article{a1a61347f0de4d8ba5ee739f5edeefb6,
title = "High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: The BARI 2D baseline data",
abstract = "Background: We describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality. Methods: Study participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated. Results: Two thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23{\%} had an eGFR ≥60 mL/min/1.73 m2 with either microalbuminuria (>30 ACR; 17{\%}) or macroalbuminuria (>300 ACR; 6{\%}). Twenty-one percent had a reduced eGFR <60 mL/min/1.73 m2; 52{\%} with reduced eGFR had no albuminuria; 28{\%} had microalbuminuria, and 20{\%} had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR. Conclusion: Kidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33{\%}. Reduced eGFR was present in 21{\%}, and half the patients with reduced eGFR had no evidence of albuminuria.",
author = "Barry Wall and Hardison, {Regina M.} and Molitch, {Mark E.} and Marroquin, {Oscar C.} and McGill, {Janet B.} and August, {Phyllis A.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1097/MAJ.0b013e3181d430ad",
language = "English (US)",
volume = "339",
pages = "401--410",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease

T2 - The BARI 2D baseline data

AU - Wall, Barry

AU - Hardison, Regina M.

AU - Molitch, Mark E.

AU - Marroquin, Oscar C.

AU - McGill, Janet B.

AU - August, Phyllis A.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Background: We describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality. Methods: Study participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated. Results: Two thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23% had an eGFR ≥60 mL/min/1.73 m2 with either microalbuminuria (>30 ACR; 17%) or macroalbuminuria (>300 ACR; 6%). Twenty-one percent had a reduced eGFR <60 mL/min/1.73 m2; 52% with reduced eGFR had no albuminuria; 28% had microalbuminuria, and 20% had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR. Conclusion: Kidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33%. Reduced eGFR was present in 21%, and half the patients with reduced eGFR had no evidence of albuminuria.

AB - Background: We describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality. Methods: Study participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated. Results: Two thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23% had an eGFR ≥60 mL/min/1.73 m2 with either microalbuminuria (>30 ACR; 17%) or macroalbuminuria (>300 ACR; 6%). Twenty-one percent had a reduced eGFR <60 mL/min/1.73 m2; 52% with reduced eGFR had no albuminuria; 28% had microalbuminuria, and 20% had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR. Conclusion: Kidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33%. Reduced eGFR was present in 21%, and half the patients with reduced eGFR had no evidence of albuminuria.

UR - http://www.scopus.com/inward/record.url?scp=77952279378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952279378&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0b013e3181d430ad

DO - 10.1097/MAJ.0b013e3181d430ad

M3 - Article

C2 - 20375690

AN - SCOPUS:77952279378

VL - 339

SP - 401

EP - 410

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 5

ER -